Whitehawk Therapeutics is an ADC-focused oncology company applying advanced technologies to established tumor biology to efficiently deliver improved cancer treatments.
Building on the momentum of drug conjugate technologies, Whitehawk’s three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers, including in significant populations like lung and ovarian. These assets are in-licensed from WuXi Biologics under an exclusive development and global commercialization agreement.
As a pragmatic, discerning and agile organization, we are unafraid to make boldly pragmatic choices. We’re experts in the business of biotech, from therapeutics R&D through commercialization, applying our collective talents to intentional drug development.
More information on the Company is available at www.whitehawktx.com.
Company Details
- Employees
- 19
- Address
- The Limitations Of Earlier Linker-Payload Chemistries
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://whitehawktx.com/
Whitehawk Therapeutics Questions
Whitehawk Therapeutics's website is https://whitehawktx.com/
Whitehawk Therapeutics's LinkedIn profile is https://www.linkedin.com/company/whitehawk-therapeutics
Whitehawk Therapeutics has
19 employees.
View email and phone details for 19
employees at Whitehawk Therapeutics.
Whitehawk Therapeutics's industry is
Biotechnology Research
Whitehawk Therapeutics's top competitors are
Nuvation Bio,
Beone Medicines,
Elevation Oncology,
Aadi Bioscience, Inc,
Arcus Biosciences,
Profoundbio,
Tyra Biosciences,
Revolution Medicines,
Orca Bio,
Vera Therapeutics, Inc..
Whitehawk Therapeutics's categories are Biotechnology Research
